Home | Welcome to Contract Pharma   
Last Updated Monday, October 20 2014
Print

Trials & Filings in Brief: Sept. 25, 2013



Acorda, Amarin, Bayer, Cardiome, Cornerstone, KemPharm, Merck Serono and Mylan



By Gil Roth



Published September 25, 2013
Related Searches: Phase III Phase II www.contractpharma.com contractpharma.com
Phase II
Cornerstone begins trial for myelodysplastic syndrome . . . read more

Acorda enrolls for spinal injury trial . . . read more

Phase III
Merck Serono to conduct cancer immunotherapy trial . . . read more

Generics
Mylan sued over first-to-file challenge of Savella . . . read more

Outcomes
Amarin enrolls 6,000+ in REDUCE-IT CV trial . . . read more

Approvals
Cardiome gains Brinavess approval in Turkey . . . read more

Bioequivalence
KemPharm's abuse-resistant opioid shows equivalence to RLD . . . read more

Filings
Bayer receives orphan status for riociguat . . . read more


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On